DCA
LLY icon

DB&C Advisors’s Eli Lilly LLY Stock Holding History

DB&C Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
+185
New +$189K 0.24% 71
2026
Q1 		– Sell
-192
Closed -$206K – 71
2025
Q4 		$206K Buy
+192
New +$184K 0.26% 66

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DB&C Advisors's LLY Position: Q2 2026 in Review

DB&C Advisors opened a new position in Eli Lilly (LLY) in Q2 2026: 185 shares worth $222K. The stake represents 0.24% of the portfolio and ranks #71 among its holdings. This is a return to the name: DB&C Advisors previously reported a position in LLY as recently as Q4 2025.

DB&C Advisors first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. 4,612 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • DB&C Advisors held 185 shares of Eli Lilly worth $222K as of Q2 2026.
  • Eli Lilly was a new DB&C Advisors position in Q2 2026.
  • Eli Lilly made up 0.24% of DB&C Advisors's portfolio in Q2 2026, its #71 holding.
  • DB&C Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • 4,612 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on DB&C Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.